Biomarkers of acute kidney injury

Authors:
  • ASAlex Júnior Schäfer
    Alex Júnior Schäfer
  • ASAline Liene da Silva
    Aline Liene da Silva
  • AGArianne Ditzel Gaspar
    Arianne Ditzel Gaspar
  • DSDeborah Francisca Scarpari
    Deborah Francisca Scarpari
  • JAJulia Barazetti Ferrari Alves
    Julia Barazetti Ferrari Alves
  • RNRodolfo Girelli Neto
    Rodolfo Girelli Neto
  • TOThaís Figueiredo Teodoro de Oliveira
    Thaís Figueiredo Teodoro de Oliveira

Abstract
Creatinine remains the standard for laboratory diagnosis of AKI. Efforts to prevent nephrotoxicity have been harmed by the delay in the diagnosis of AKI criteria by using only the creatinine as a marker, therefore there is great interest in identifying early reliable biomarkers. Moreover, early treatment of ARF can be correlated with a better prognosis and identification of biomarkers for early diagnosis would improve the efficacy of a therapeutic strategy. Thus, it becomes imperative to find biomarkers that can stratify correctly the extent of renal damage that each patient has suffered and the risk of developing chronic kidney disease (CKD). Here, we review the main features of emerging biomarkers in nephrology.